![](/img/cover-not-exists.png)
Protective effect of rimonabant, a canabinoid receptor 1 antagonist on nonalcoholic fatty liver disease in a rat model by modulating the hepatic expression of activin A and follistatin .
Hussien, Noha Ibrahim, El-kerdasy, Hanan I., Ibrahim, Mohamed El-TantawyLanguage:
english
Journal:
Canadian Journal of Physiology and Pharmacology
DOI:
10.1139/cjpp-2017-0070
Date:
July, 2017
File:
PDF, 1.66 MB
english, 2017